PMV PHARMACEUTICALS INC's ticker is PMVP and the CUSIP is 69353Y103. A total of 109 filers reported holding PMV PHARMACEUTICALS INC in Q2 2022. The put-call ratio across all filers is 0.34 and the average weighting 0.9%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $2,303,516 | -33.1% | 264,772 | -8.5% | 0.02% | -48.6% |
| Q3 2022 | $3,443,000 | +0.7% | 289,318 | +20.6% | 0.04% | +19.4% |
| Q2 2022 | $3,418,000 | -4.6% | 239,864 | +39.4% | 0.03% | +47.6% |
| Q1 2022 | $3,583,000 | +31.2% | 172,100 | +45.6% | 0.02% | +50.0% |
| Q4 2021 | $2,730,000 | +15.3% | 118,194 | +48.8% | 0.01% | -12.5% |
| Q3 2021 | $2,368,000 | +99.7% | 79,449 | +128.9% | 0.02% | +128.6% |
| Q2 2021 | $1,186,000 | +36.2% | 34,714 | +31.1% | 0.01% | +16.7% |
| Q1 2021 | $871,000 | – | 26,472 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| INTERWEST VENTURE MANAGEMENT CO | 1,614,911 | $9,915,554 | 48.05% |
| OUP Management Co., LLC | 989,232 | $6,073,884 | 13.66% |
| Euclidean Capital LLC | 5,255,286 | $32,267,456 | 3.52% |
| Tri Locum Partners LP | 821,384 | $5,043,298 | 1.61% |
| Ghost Tree Capital, LLC | 705,881 | $4,334,109 | 1.42% |
| Boxer Capital, LLC | 3,163,795 | $19,425,701 | 1.03% |
| Mesirow Financial Investment Management, Inc. | 34,748 | $213,353 | 0.93% |
| Orbimed Advisors | 6,563,077 | $40,297,293 | 0.86% |
| Octagon Capital Advisors LP | 904,000 | $5,550,560 | 0.85% |
| Nextech Invest Ltd. | 421,284 | $2,586,684 | 0.78% |